As one of the longest-standing thalassemia care centers in the country, we possess extensive experience and treatment expertise. The Weill Cornell Medicine New York Comprehensive Thalassemia Center is trusted to provide up-to-date guidelines as well as support for hematologists and primary care providers. We also have a rich history of participating in and conducting clinical trials, resulting in major care advancements in care and outcome improvements through a reduction in morbidity.
Guidelines developed at the New York Comprehensive Thalassemia Center, based on review of available literature and our own experience, include:
- Guidelines for Transfusion-Dependent Thalassemia (TDT) Transfusion Therapy
- Guidelines for Comprehensive Thalassemia Monitoring
- Guidelines for Thalassemia Chelation (Transfusion-Dependent and Non-Transfusion-Dependent Patients)
- Guidelines for Thalassemia Patient Pregnancy Management
View and participate in ongoing clinical trials at the New York Comprehensive Thalassemia Center.